News - Page 213 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Algernon Pharmaceuticals Launches Stroke Treatment Clinical Research Program with Psychedelic Drug DMT “The Spirit Molecule”

Algernon Pharmaceuticals Launches Stroke Treatment Clinical Research Program with Psychedelic Drug DMT “The Spirit Molecule”

Post published:February 1, 2021
Post category:Press Release

Numinus Wellness Closes Q1 2021 with Strong Cash Position and Industry Firsts

Post published:January 29, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: Psychedelics ETF Launches; atai Collaborate with Mass General; McGill Publishes LSD Research

Psychedelic Bulletin: Psychedelics ETF Launches; atai Collaborate with Mass General; McGill Publishes LSD Research

Post published:January 29, 2021
Post category:Psychedelic Bulletin

Read more about the article Psyence Group Completes First Cultivation Cycle of Medical Psilocybin Mushrooms at Its Commercially Licensed Facility

Psyence Group Completes First Cultivation Cycle of Medical Psilocybin Mushrooms at Its Commercially Licensed Facility

Post published:January 29, 2021
Post category:Press Release

Read more about the article Red Light Holland Announces Closing of $9.77 Million Bought Deal Financing

Red Light Holland Announces Closing of $9.77 Million Bought Deal Financing

Post published:January 28, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Common Shares to Trade on the OTCQX Best Market

Field Trip Health Ltd. Common Shares to Trade on the OTCQX Best Market

Post published:January 28, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland

Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland

Post published:January 28, 2021
Post category:Press Release

Read more about the article BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies

Post published:January 28, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Files Application to list to the NASDAQ

Mydecine Innovations Group Files Application to list to the NASDAQ

Post published:January 27, 2021
Post category:Press Release

Read more about the article NeonMind Appoints Robert Tessarolo as President and Chief Executive Officer

NeonMind Appoints Robert Tessarolo as President and Chief Executive Officer

Post published:January 27, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.